Summary
Efficient gene transfer into T lymphocytes may allow the treatment of several genetic dysfunctions of the hematopoietic system, such as severe combined immunodeficiency, and the development of novel therapeutic strategies for diseases such as cancers and acquired diseases such as AIDS. Lentiviral vectors can transduce many types of nonproliferating cells, with the exception of some particular quiescent cell types such as resting T cells. Completion of reverse transcription, nuclear import, and subsequent integration of the lentivirus genome do not occur in these cells unless they are activated via the T-cell receptor (TCR) and/or by cytokines inducing resting T cells to enter in G1b phase of the cell cycle. In T-cell-based gene therapy trials performed to date, cells have been preactivated via their cognate antigen receptor (TCR). However, TCR stimulation shifts the T cells from naïve to memory phenotype and leads to skewing of the T-cell population. Since, especially the naïve T cells will provide a long-lasting immune reconstitution to patients these are the cells that need to be transduced for effective gene therapy. Now it is clear that use of the survival cytokines, IL-2 or IL-7, allows an efficient lentiviral vector gene transfer and could preserve a functional T-cell repertoire while maintaining an appropriate proportion of naïve and memory T cells. In this protocol we give details on lentiviral transduction of T cells using TCR-stimulation or rIL-7 prestimulation. In addition, we describe the use of a new generation of lentiviral vectors displaying T-cell-activating ligands at their surface for targeted T-cell gene transfer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Blaese, R.M., Culver, K.W., Miller, A.D., Carster, C.S., Fleisher, T., Clerci, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., Greenblatt, J.J., Rosenberg, S.A., Klein, H., Berger, M., Mullen, C.A., Ramsey, W.J., Muul, L., Morgan, R.A., Anderson, W. F. (1995). T-lymphocyte directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270, 275–280
Bordignon, C., Notaranglo, L.D., Nobili, N., Ferrari, G., Casorati, G., Panina, P., Mazzo-lana, E., Maggioni, D., Rossi, C., Ser vida, P., Ugazio, A.G., Mavillo, F. (1995). Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470–475
Mitsuyasu, R.T., Anton, P.A., Deeks, S.G., Scadden, D.T., Connick, E., Downs, M.T., Bakker, A., Roberts, M.R., June, C.H., Jalali, S., Lin, A.A., Pennathur-Das, R., Hege, K.M. (2000). Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects. Blood 96 (3), 785–93
Deeks, S.G., Wagner, B., Anton, P.A., Mit-suyasu, R.T., Scadden, D.T., Huang, C., Macken, C., Richman, D.D., Christopher-son, C., June, C.H., Lazar, R., Broad, D.F., Jalali, S., Hege, K.M. (2002). A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther 5 (6), 788–797
Recchia, A., Bonini, C., Magnani, Z., Urbinati, F., Sartori, D., Muraro, S., Tagliafico, E., Bondanza, A., Stanghellini, M.T., Bernardi, M., Pescarollo, A., Ciceri, F., Bordignon, C., Mavilio, F. (2006). Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells. Proc Natl Acad Sci U S A 103 (5), 1457–1462
Buchschacher, G.L., Wong-Staal, F. (2002). Approaches to gene therapy for human immunodeficiency virus infection. Hum Gene Ther 12, 1013–1019
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.P., Thrasher, A.J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., Fischer, A., Davies, E.G., Kuis, W., Leiva, L., Cavazzana-Calvo, M. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med 346, 1185–1193
Cavazzana-Calvo, M., Fischer, A. (2004). Efficacy of gene therapy for SCID is being confirmed. Lancet 364 (9452), 2155–2156
Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., Marinello, E., Cattaneo, F., Vai, S., Ser vida, P., Miniero, R., Roncarolo, M.G., Bordignon, C. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science, 296 (5577), 2410–2413
Powell, J.S., Ragni, M.V., White, G.C. 2nd, Lusher, J.M., Hillman-Wiseman, C., Moon, T.E., Cole, V., Ramanathan-Girish, S., Roehl, H., Sajjadi, N., Jolly, D.J., Hurst, D. (2003). Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion. Blood 102 (6), 2038–2045
Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., Kunkel, H., Naundorf, S., Brinkmann, A., Deichmann, A., Fischer, M., Ball, C., Pilz, I., Dunbar, C., Du, Y., Jenkins, N.A., Copeland, N.G., Luthi, U., Hassan, M., Thrasher, A.J., Hoelzer, D., von Kalle, C., Seger, R., Grez, M. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12 (4), 401–409
Tjonnfjord, G.E., Steen, R., Veiby, O.P., Friedrich, W., Egeland, T. (1994). Evidence for engraftment of donor-type multipotent CD34— cells in a patient with selective T-lym-phocyte reconstitution after bone marrow transplantation for B-SCID. Blood 84 (10), 3584–3589
Hirschhorn, R., Yang, D.R., Puck, J.M., Huie, M.L., Jiang, C.K., Kurlandsky, L.E. (1996). Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adeno-sine deaminase deficiency. Nat Genet 13 (3), 290–295
Stephan, V., Wahn, V., Le Deist, F., Dirk-sen, U., Broker, B., Muller-Fleckenstein, I., Horneff, G., Schroten, H., Fischer, A., de Saint Basile, G. (1996). A typical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med 335 (21), 1563 –1567
Aiuti, A., Vai, S., Mortellaro, A., Casorati, G., Ficara, F., Andolfi, G., Ferrari, G., Tabucchi, A., Carlucci, F., Ochs, H.D., Notarangelo, L.D., Roncarolo, M.G., Bordignon, C. (2002) Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med 8 (5), 423–425
Dupre, L., Trifari, S., Follenzi, A., Marangoni, F., Lain de Lera, T., Bernad, A., Martino, S., Tsuchiya, S., Bordignon, C., Naldini, L., Aiuti, A., Roncarolo, M.G. (2004). Lentiviral vector-mediated gene transfer in T cells from Wiskott—Aldrich syndrome patients leads to functional correction. Mol Ther 10 (5), 903–915
Szydlo, R., Goldman, J.M., Klein, J.P., Gale, R.P., Ash, R.C., Bach, F.H., Bradley, B.A., Casper, J.T., Flomenberg, N., Gajewski, J.L., Gluckman, E., Henslee-Downey, P.J., Hows, J.M., Jacobsen, N., Kolb, H.J., Lowenberg, B., Masaoka, T., Rowlings, P.A., Sondel, P.M., van Bekkum, D.W., van Rood, J.J., Vowels, M.R., Zhang, M.J., Horowitz, M.M. (1997). Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 15 (5), 1767–1777
Vigorito, A.C., Azevedo, W.M., Marques, J.F., Azevedo, A.M., Eid, K.A., Aranha, F.J., Lorand-Metze, I., Oliveira, G.B., Correa, M.E., Reis, A.R., Miranda, E.C., de Souza, C.A. (1998). A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 22 (12), 1145–1151
Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B. (1990). Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75 (3), 555–562
Tiberghien, P., Ferrand, C., Lioure, B., Milpied, N., Angonin, R., Deconinck, E., Certoux, J.M., Robinet, E., Saas, P., Petracca, B., Juttner, C., Reynolds, C.W., Longo, D.L., Herve, P., Cahn, J.Y. (2001) Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 97 (1), 63–72
Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., Bordi-gnon, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276 (5319), 1719–1724
Bondanza, A., Valtolina, V., Magnani, Z., Ponzoni, M., Fleischhauer, K., Bonyhadi, M., Traversari, C., Sanvito, F., Toma, S., Radriz-zani, M., La Seta-Catamancio, S., Ciceri, F., Bordignon, C., Bonini, C. (2006). Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107 (5), 1828–1836
Chun, T. W., Stuyver, L., Mizell, S.B., Ehler, L.A., Mican, J.A., Baseler, M., Lloyd, A.L., Nowak, M.A., Fauci, A.S. (1997). Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 94, 13193–13197
Finzi, D., Hermankova, M., Pierson, T., Car-ruth, L.M., Buck, C., Chaisson, R.E., Quinn, T.C., Chadwick, K., Margolick, J., Brook-meyer, R., Gallant, J., Markowitz, M., Ho, D.D., Richman, D.D., Siliciano, R.F. (1997). Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295–1300
Woffendin, C., Ranga, U., Yang, Z., Xu, L., Nabel, G.J. (1996). Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc Natl Acad Sci U S A93, 2889–2894
Ranga, U., Woffendin, C., Verma, S., Xu, L., June, C.H., Bishop, D.K., Nabel, G.J. (1998). Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals. Proc Natl Acad Sci U S A95, 1201–1206
Braun, S.E., Wong, F.E., Connole, M., Qiu, G., Lee, L., Gillis, J., Lu, X., Humeau, L., Sle-pushkin, V., Binder, G.K., Dropulic, B., Johnson, R.P. (2005). Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells. Mol Ther 12 (6), 1157–1167
Humeau, L.M., Binder, G.K., Lu, X., Slepush-kin, V., Merling, R., Echeagaray, P., Pereira, M., Slepushkina, T., Barnett, S., Dropulic, L.K., Carroll, R., Levine, B.L., June, C.H., Dropulic, B. (2004). Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol Ther 9 (6), 902–913
Levine, B.L., Humeau, L.M., Boyer, J., Mac-Gregor, R.R., Rebello, T., Lu, X., Binder, G.K., Slepushkin, V., Lemiale, F., Mascola, J.R., Bushman, F.D., Dropulic, B., June, C.H. (2006). Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci U S A 103 (46), 17372–17377
Hildinger, M., Dittmar, M.T., Schult-Diet-rich, P., Fehse, B., Schnierle, B.S., Thaler, S., Stiegler, G., Welker, R., von Laer, D. (2001). Membrane-anchored peptide inhibits human immunodeficiency virus entry. J. Virol 75, 3038–3042
Egelhofer, M., Brandenburg, G., Martinius, H., Schult-Dietrich, P., Melikyan, G., Kunert, R., Baum, C., Choi, I., Alexandrov, A., von Laer, D. (2004). Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J Virol 78 (2), 568–575
Anderson, W. F. (1998). Human gene therapy. Nature 392, 25–30
Miller, D.G., Adam, M.A., Miller, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10, 4239–4242
Roe, T., Reynolds, T.C., Yu, G., Brown, P.O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J12, 2099–2108
Vigna, E., Naldini, L. (2000). Lentiviral vec-tors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med2, 308–316
Bukrinsky, M.I., Sharova, N., Dempsey, M.P., Stanwick, T.L., Haggerty, S., Stevenson, M. (1992). Active nuclear import of human immunodeficiency virus type 1 preintegra-tion complexes. Proc Natl Acad Sci U S A89, 6580–6584
Lewis, P., Hensel, M., Emerman, M. (1992). Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J11, 3053–3058
Weinberg, J.B., Matthews, T.J., Cullen, B.R., Malim, M.H. (1991). Productive human immunodeficiency virus type 1 (HIV-1) infection of non proliferative human cells. J Exp Med174, 1477–1482
Sutton, R.E., Reitsma, M.J., Uchida, N., Brown, P.O. (1999). Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J Virol73, 3649–3660
Kootstra, N.A., Zwart, B.M., Schuitemaker, H. (2000). Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle. J Virol74, 1712–1717
Neil, S., Martin, F., Ikeda, Y., Collins, M. (2001). Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol75, 5448–5456
Dardalhon, V., Herpers, B., Noraz, N., Pflumio, F., Guetard, D., Leveau, C., Dubart-kupper-schmitt, A., Charneau, P., Taylor, N. (2001). Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene ther8, 190–198
Stevenson, M., Stanwick, T.L., Dempsey, M.P., Lamonica, C.A. (1990). HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J9, 1551–1560
Sun, Y., Pinchuk, L.M., Agy, M.B., Clark, E.A. (1997). Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway. J Immunol 158, 512–517
Zack, J.A., Haislip, A.M., Krogstad, P., Chen, I.S.Y. (1992). Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 68, 1717–1725
Zack, J.A. (1995). The role of the cell cycle in HIV-1 infection. Adv.Exp.Med.Biol374, 27–31
Korin, Y.D., Zack, J.A. (1993). Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 72, 3161–3168
Bukrinsky, M.I., Haggerty, S., Dempsey, M.P., Sharova, N., Adzhubel, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., Stevenson, M. (1993). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666–669
Korin, Y.D., Zack, J.A. (1999). Nonproduc-tive human immunodeficiency virus type 1 infection in nucleoside-treated Go lymphocytes. J Virol 73, 6526–6532
Unutmaz, D., KewalRamani, V.N., Marmon, S., Littman, D.R. (1999). Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 189, 1735–1746
Maurice, M., Verhoeyen, E., Salmon, P., Trono, D., Russell, S.J., Cosset, F.-L. (2002). Efficient gene transfer into human primary blood lymphocytes by surface-engineered len-tiviral vectors that display a T cell-activating polypeptide. Blood 99, 2342–2350.
Roth, M.D. (1994). Interleukin 2 induces the expression of CD45RO and the memory phe-notype by CD45RA+ peripheral blood lymphocytes. J Exp Med 179 (3), 857–864
Marktel, S., Magnani, Z., Ciceri, F., Cazza-niga, S., Riddell, S.R., Traversari, C., Bordi-gnon, C., Bonini, C. (2003). Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconsti-tution after hematopoietic T-cell-depleted stem cell transplantation. Blood 101 (4), 1290–1298
Ferrand, C., Robinet, E., Contassot, E., Cer-toux, J.M., Lim, A., Her ve, P., Tiberghien, P. (2000). Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire. Hum Gene Ther 11 (8), 1151–1164
Verhoeyen, E., Dardalhon, V., Ducrey-Rundquist, O., Trono, D., Taylor, N., Cosset, F.-L. (2003). IL-7 surface-engineered lentivi-ral vectors promote survival and efficient gene transfer in resting primary T-lymphocytes. Blood 101, 2167–2174
Fry, T.J., Mackall, C.L. (2001) Interleukin-7: master regulator of peripheral T-cell homeos-tasis? Trends Immunol 22 (10), 564–571
Geiselhart, L.A., Humphries, C.A., Grego-rio, T.A., Mou, S., Subleski, J., Komschlies, K.L. (2001). IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J Immunol 166 (5), 3019–3027
Rathmell, J.C., Farkash, E.A., Gao, W., Thompson, C.B. (2001). IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 167 (12), 6869–6876
Cavalieri, S., Cazzaniga, S., Geuna, M., Mag-nani, Z., Bordignon, C., Naldini, L., Bonini, C. (2003). Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 102 (2), 497–505
Dardalhon, V., Jaleco, S., Kinet, S., Herpers, B., Steinberg, M., Ferrand, C., Froger, D., Leveau, C., Tiberghien, P., Charneau, P., Noraz, N., Taylor, N. (2001). IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells. Proc Natl Acad Sci U S A 98 (16), 9277–82
Ducrey-Rundquist, O., Guyader, M., Trono, D. (2002). Modalities of interleukin-7-in-duced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J Virol 76 (18), 9103–9111
Swainson, L., Verhoeyen, E., Cosset, F.L., Taylor, N. (2006). IL-7R alpha gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes. J Immunol 176 (11), 6702–6708
Soares, M.V., Borthwick, N.J., Maini, M.K., Janossy, G., Salmon, M., Akbar, A.N. (1998). IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J Immunol 161 (11), 5909–5917
Webb, L.M., Foxwell, B.M., Feldmann, M. (1999) Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ T-cell pool. Immunology 98 (3), 400–405
Frecha, C., Costa, C., Negre, D., Gauthier, E., Russell, S.J., Cosset, F.L., Verhoeyen, E. (2008) Stable transduction of quiescent T-cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. Blood, Sep 23 [Epub ahead of print]
Acknowledgments
This work was supported by the Agence Nationale pour la Recherche contre le SIDA (ANRS), the European community (contract LSHB-CT-2004-005242, “Consert”), and INSERM. We acknowledge the contributions of Naomi Taylor, Louise Swainson, and Valerie Dardahlon to these studies.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Verhoeyen, E., Costa, C., Cosset, FL. (2009). Lentiviral Vector Gene Transfer into Human T Cells. In: Baum, C. (eds) Genetic Modification of Hematopoietic Stem Cells. Methods In Molecular Biology™, vol 506. Humana Press. https://doi.org/10.1007/978-1-59745-409-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-409-4_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-980-2
Online ISBN: 978-1-59745-409-4
eBook Packages: Springer Protocols